{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:33Z","timestamp":1792783653339,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Byron L. Lam"},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"John R. Guy"},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Allergan, Data Safety Monitoring Committee"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ajo.2018.08.038","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T14:13:20Z","timestamp":1536156800000},"page":"xxv-xxix","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases"],"prefix":"10.1016","volume":"196","author":[{"given":"Janet L.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2018.08.038_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mgg3.208","article-title":"Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy","volume":"4","author":"Freund","year":"2016","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.ajo.2018.08.038_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnins.2017.00174","article-title":"Retinal gene therapy: surgical vector delivery in the translation to clinical trials","volume":"11","author":"Ochakovski","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ajo.2018.08.038_bib3","article-title":"Semiautomated subretinal fluid injection method using viscous fluid injection mode","author":"Kwon","year":"2018","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.038_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.6.4.4","article-title":"Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in\u00a0vitro and in\u00a0vivo analysis","volume":"6","author":"Salvetti","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.038_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/hgtb.2016.086","article-title":"Evaluation of an optimized injection system for retinal gene therapy in human patients","volume":"27","author":"Fischer","year":"2016","journal-title":"Hum Gene Ther Methods"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.038_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICU.0000000000000476","article-title":"Robotic-assisted surgery in ophthalmology","volume":"29","author":"de Smet","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"issue":"20","key":"10.1016\/j.ajo.2018.08.038_bib7","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia","volume":"374","author":"Edwards","year":"2016","journal-title":"N Engl J Med"},{"issue":"10097","key":"10.1016\/j.ajo.2018.08.038_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"issue":"9701","key":"10.1016\/j.ajo.2018.08.038_bib9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.038_bib10","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.038_bib11","doi-asserted-by":"crossref","first-page":"ORSFn1","DOI":"10.1167\/iovs.15-17654","article-title":"Retinal structure measurements as inclusion criteria for stem cell-based therapies of retinal degenerations","volume":"57","author":"Jacobson","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.038_bib12","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1167\/iovs.13-13454","article-title":"High-resolution adaptive optics retinal imaging of cellular structure in choroideremia","volume":"55","author":"Morgan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.038_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/gim.2013.148","article-title":"\u201cIs a cure in my sight?\u201d Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials","volume":"16","author":"Benjaminy","year":"2014","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.038_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ophtha.2016.10.022","article-title":"Natural history of the central structural abnormalities in choroideremia: a prospective cross-sectional study","volume":"124","author":"Aleman","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.08.038_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2017.05.002","article-title":"Measurement and reproducibility of preserved ellipsoid zone area and preserved retinal pigment epithelium area in eyes with choroideremia","volume":"179","author":"Hariri","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.038_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.038_bib17","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1167\/iovs.17-22402","article-title":"Subretinal injection for gene therapy does not cause clinically significant outer nuclear layer thinning in normal primate foveae","volume":"58","author":"Ochakovski","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2018.08.038_bib18","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1167\/iovs.17-22737","article-title":"Surgically induced focal retinal detachment does not cause detectable SD-OCT retinal changes in normal human retina","volume":"58","author":"Kogachi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2018.08.038_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2017.02.018","article-title":"Gene therapy in neovascular age-related macular degeneration: three-year follow-up of a phase 1 randomized dose escalation trial","volume":"177","author":"Constable","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"9923","key":"10.1016\/j.ajo.2018.08.038_bib20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2018.08.038_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2018.06.011","article-title":"Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience","volume":"193","author":"Dimopoulos","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.038_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2018.08.038_bib23","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1167\/iovs.18-24333","article-title":"Surgical removal of internal limiting membrane and layering of AAV vector on the retina under air enhances gene transfection in a nonhuman primate","volume":"59","author":"Teo","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2018.08.038_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mehy.2016.11.017","article-title":"Internal limiting membrane: the innermost retinal barrier","volume":"98","author":"Chawla","year":"2017","journal-title":"Med Hypotheses"},{"issue":"13","key":"10.1016\/j.ajo.2018.08.038_bib25","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1167\/iovs.17-22473","article-title":"Superior retinal gene transfer and biodistribution profile of subretinal versus intravitreal delivery of AAV8 in nonhuman primates","volume":"58","author":"Seitz","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2018.08.038_bib27","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2018.08.038_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4939-7522-8_18","article-title":"Subretinal and intravitreal retinal injections in monkeys","volume":"1715","author":"Dauletbekov","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajo.2018.08.038_bib29","article-title":"Intraoperative use of microscope-integrated optical coherence tomography for subretinal gene therapy delivery","author":"Gregori","year":"2017","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2018.08.038_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.7.2.19","article-title":"Volumetric measurement of subretinal blebs using microscope-integrated optical coherence tomography","volume":"7","author":"Hsu","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.038_bib31","doi-asserted-by":"crossref","first-page":"e60218","DOI":"10.1371\/journal.pone.0060218","article-title":"Evaluation of lateral spread of transgene expression following subretinal AAV-mediated gene delivery in dogs","volume":"8","author":"Bruewer","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2018.08.038_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96029","article-title":"Noninvasive gene delivery to foveal cones for vision restoration","volume":"3","author":"Khabou","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.038_bib33","doi-asserted-by":"crossref","first-page":"a017293","DOI":"10.1101\/cshperspect.a017293","article-title":"Gene therapy for choroideremia using an adeno-associated viral (AAV) vector","volume":"5","author":"Barnard","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.ajo.2018.08.038_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/gt.2016.66","article-title":"Development of an optimized AAV2\/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65","volume":"23","author":"Georgiadis","year":"2016","journal-title":"Gene Ther"},{"issue":"5-6","key":"10.1016\/j.ajo.2018.08.038_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jgm.2768","article-title":"Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in\u00a0vitro and in\u00a0vivo models","volume":"16","author":"Black","year":"2014","journal-title":"J Gene Med"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.038_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","article-title":"Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis","volume":"26","author":"Le Meur","year":"2018","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.038_bib37","doi-asserted-by":"crossref","first-page":"a017301","DOI":"10.1101\/cshperspect.a017301","article-title":"Gene therapy of ABCA4-associated diseases","volume":"5","author":"Auricchio","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.038_bib38","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1172\/JCI120429","article-title":"Gene therapy and genome surgery in the retina","volume":"128","author":"DiCarlo","year":"2018","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.038_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/156652306779010688","article-title":"Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import","volume":"6","author":"Vaughan","year":"2006","journal-title":"Curr Gene Ther"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.038_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.gt.3303082","article-title":"How not to be seen: immune-evasion strategies in gene therapy","volume":"15","author":"Zaldumbide","year":"2008","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.038_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molmed.2008.11.005","article-title":"Immune barriers to successful gene therapy","volume":"15","author":"Wu","year":"2009","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.038_bib42","doi-asserted-by":"crossref","first-page":"e0119541","DOI":"10.1371\/journal.pone.0119541","article-title":"Retinal photoreceptor expresses toll-like receptors (TLRs) and elicits innate responses following TLR ligand and bacterial challenge","volume":"10","author":"Singh","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.038_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.038_bib44","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1038\/s41598-017-18236-7","article-title":"Involvement of innate immune system in late stages of inherited photoreceptor degeneration","volume":"7","author":"Sudharsan","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ajo.2018.08.038_bib45","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","article-title":"Inflammation and its role in age-related macular degeneration","volume":"73","author":"Kauppinen","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.038_bib46","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1167\/iovs.17-22494","article-title":"Humoral immune response after intravitreal but not after subretinal AAV8 in primates and patients","volume":"59","author":"Reichel","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418304999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418304999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:39:19Z","timestamp":1757597959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418304999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"alternative-id":["S0002939418304999"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.08.038","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}